![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
![[thumbnail of 14478oa.pdf]](https://edoc.mdc-berlin.de/style/images/fileicons/application_pdf.png) |
PDF
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB |
| Item Type: | Article |
|---|---|
| Title: | Novel drug candidates for the treatment of metastatic colorectal cancer through global inverse gene-expression profiling |
| Creators Name: | van Noort, V., Schoelch, S., Iskar, M., Zeller, G., Ostertag, K., Schweitzer, C., Werner, K., Weitz, J., Koch, M. and Bork, P. |
| Abstract: | Drug-induced gene-expression profiles that invert disease profiles have recently been illustrated to be a starting point for drug repositioning. In this study, we validate this approach and focus on prediction of novel drugs for colorectal cancer, for which there is a pressing need to find novel antimetastatic compounds. We computationally predicted three novel and still unknown compounds against colorectal cancer: citalopram (an antidepressant), troglitazone (an antidiabetic), and enilconazole (a fungicide). We verified the compounds by in vitro assays of clonogenic survival, proliferation, and migration and in a subcutaneous mouse model. We found evidence that the mode of action of these compounds may be through inhibition of TGF{beta} signaling. Furthermore, one compound, citalopram, reduced tumor size as well as the number of circulating tumor cells and metastases in an orthotopic mouse model of colorectal cancer. This study proposes citalopram as a potential therapeutic option for patients with colorectal cancer, illustrating the potential of systems pharmacology. |
| Keywords: | Antineoplastic Agents, Chromans, Citalopram, Colorectal Neoplasms, Gene Expression Profiling, HCT116 Cells, HT29 Cells, Imidazoles, Inbred NOD Mice, Neoplastic Cells, Circulating, Signal Transduction, Thiazolidinediones, Transcriptome, Transforming Growth Factor beta, Xenograft Model Antitumor Assays, Animals, Mice |
| Source: | Cancer Research |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Volume: | 74 |
| Number: | 20 |
| Page Range: | 5690-5699 |
| Date: | 15 October 2014 |
| Official Publication: | https://doi.org/10.1158/0008-5472.CAN-13-3540 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
